{"filing":{"accession_number":"0001537435-26-000053","cik":"0001537435","ticker":"TGEN","company_name":"TECOGEN INC.","form":"8-K","filing_date":"2026-07-01","report_date":null,"primary_document":"tgen-20260626.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1537435/000153743526000053/tgen-20260626.htm"},"events":[{"id":15369,"run_id":13713,"accession_number":"0001537435-26-000053","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The disclosure centers on compensatory arrangements for the CEO and named executive officers, including restricted stock awards, incentive stock options, and base salary increases approved by the Board on June 26, 2026. The filing explicitly states the awards were granted \"in order to align the economic interests\" of executives with the Company and stockholders, and details the specific equity grants (174,081 restricted shares and 26,041 options for CEO Abinand Rangesh) and salary increases (5% for Rangesh to $220,500; 3% for other NEOs). This is a classic exec_compensation disclosure under Item 5.02(e).","company_name":"TECOGEN INC.","ticker":"TGEN","filing_date":"2026-07-01","form":"8-K","submitted_at":null,"items":[{"id":13104,"accession_number":"0001537435-26-000053","item_number":"5.02","item_title":"Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure centers on compensatory arrangements for the CEO and named executive officers, including restricted stock awards, incentive stock options, and base salary increases approved by the Board on June 26, 2026. The filing explicitly states the awards were granted \"in order to align the economic interests\" of executives with the Company and stockholders, and details the specific equity grants (174,081 restricted shares and 26,041 options for CEO Abinand Rangesh) and salary increases (5% for Rangesh to $220,500; 3% for other NEOs). This is a classic exec_compensation disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T13:16:37.618336+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":13104,"accession_number":"0001537435-26-000053","item_number":"5.02","item_title":"Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure centers on compensatory arrangements for the CEO and named executive officers, including restricted stock awards, incentive stock options, and base salary increases approved by the Board on June 26, 2026. The filing explicitly states the awards were granted \"in order to align the economic interests\" of executives with the Company and stockholders, and details the specific equity grants (174,081 restricted shares and 26,041 options for CEO Abinand Rangesh) and salary increases (5% for Rangesh to $220,500; 3% for other NEOs). This is a classic exec_compensation disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T13:16:37.618336+00:00","company_name":"TECOGEN INC.","ticker":"TGEN","filing_date":"2026-07-01"}]}